Insider Watch Reporter: Utah Medical Products, Inc. (NASDAQ:UTMD) director Ernst Hoyer, Sold $23,994 in Stock

November 23, 2016 - By Michael Collier

Insider Watch Reporter: Utah Medical Products, Inc. (NASDAQ:UTMD) director Ernst Hoyer, Sold $23,994 in Stock

Ernst Hoyer Insider Sell

director, Ernst Hoyer is the Utah Medical Products Inc’s insider who unloaded shares of Utah Medical Products Inc, 362 to be exact. The sold shares were based on a stock price per share of $66.3, with Ernst Hoyer’s stock sale worth approx. $23,994 U.S Dollars. Ernst is trying to decrease his company’s share, same as he did in the last 30 days. He sold another 3,894 shares worth $258,186 USD. This deal was conducted on November 22, 2016. A legal document that was filed with the Washington-based SEC and available for free here, shows details of the deal. At present, he holds 53,842 shares or 1.41% of Utah Medical Products Inc’s market capitalization (total value of the shares outstanding).

Insitutional Activity: The institutional sentiment decreased to 1.5 in 2016 Q2. Its down 0.40, from 1.9 in 2016Q1. The ratio fall, as 2 funds sold all Utah Medical Products, Inc. shares owned while 19 reduced positions. 11 funds bought stakes while 29 increased positions. They now own 2.27 million shares or 0.17% less from 2.27 million shares in 2016Q1.

Moreover, Teachers Advsrs has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 5,502 shares. Blackrock Institutional Trust Com Na holds 35,634 shares or 0% of its portfolio. Advisory Services Networks Ltd owns 850 shares or 0.01% of their US portfolio. Analytic Ltd Liability Co, a California-based fund reported 16,251 shares. Legal & General Gru Pcl has invested 0% of its portfolio in Utah Medical Products, Inc. (NASDAQ:UTMD). Northern Trust Corporation has 50,209 shares for 0% of their US portfolio. Moreover, Royal Retail Bank Of Canada has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 250 shares. Gsa Capital Partners Limited Liability Partnership, a United Kingdom-based fund reported 4,100 shares. Schwab Charles Inv Mngmt owns 9,691 shares or 0% of their US portfolio. State Street Corp holds 0% or 65,616 shares in its portfolio. Sei Invests accumulated 0% or 1,255 shares. Fmr Limited Liability last reported 470,889 shares in the company. Seizert Cap Prtn Ltd Llc has 0.01% invested in the company for 4,410 shares. Bank Of Ny Mellon last reported 21,549 shares in the company. Moreover, Teton Advsrs Inc has 0.03% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 5,174 shares.

Insider Transactions: Since May 25, 2016, the stock had 0 buys, and 9 sales for $786,975 net activity. $17,691 worth of shares were sold by RICHINS PAUL O on Wednesday, May 25. CORNWELL KEVIN L sold $88,071 worth of stock or 1,396 shares. $258,186 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) shares were sold by HOYER ERNST G.

The stock increased 1.65% or $1.1 during the last trading session, hitting $67.6. About 8,455 shares traded hands or 19.35% up from the average. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 5.96% since April 21, 2016 and is uptrending. It has outperformed by 0.63% the S&P500.

Utah Medical Products, Inc. is engaged in the business of producing medical devices that are disposable and for hospital use. The company has a market cap of $255.61 million. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. It has a 20.21 P/E ratio.

According to Zacks Investment Research, “Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company’s success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvements over existing clinical techniques.”

Another recent and important Utah Medical Products, Inc. (NASDAQ:UTMD) news was published by Reuters.com which published an article titled: “BRIEF-Utah Medical Products Inc increases quarterly dividend by 2 pct to $..” on November 01, 2016.

UTMD Company Profile

Utah Medical Products, Inc. (UTMD), incorporated on April 21, 1978, is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics; neonatal intensive care; gynecology/urology/electrosurgery, and blood pressure monitoring. UTMD markets a range of medical devices used in care areas, such as the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices. Domestically, UTMD’s medical devices are sold directly to clinical end user facilities by the Company’s own direct sales representatives and independent manufacturers’ representatives. In addition, some of UTMD’s devices are sold through specialty distributors, national hospital distribution companies and other medical device manufacturers. Internationally, products are sold directly to end users in the United Kingdom, Ireland and Australia, and through other medical device companies and through independent medical products distributors in other countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>